BED BATH & BEYOND, INC.
Datakwaliteit: 100%
€ 4,69
▼
€ 0,09
(-1,88%)
Marktkapitalisatie: 352,49 M
Prijs
€ 4,78
Marktkapitalisatie
352,49 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—
Quick Summary
Belangrijkste Punten
Revenue declined -21,54% annually over 5 years
Debt/Equity of 0,09 — conservative balance sheet
Negative free cash flow of -64,11 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 3,58%
Capital efficient — spends only 0,71% of revenue on capex
Groei
Revenue Growth (5Y)
-21,54%
Onder sectorgemiddelde (3,19%)
Revenue (1Y)-25,12%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-50,75%
Onder sectorgemiddelde (-12,42%)
ROIC-24,44%
Net Margin-8,10%
Op. Margin-5,86%
Veiligheid
Debt / Equity
0,09
Onder sectorgemiddelde (0,48)
Current Ratio1,17
Interest Coverage-12,12
Waardering
PE (TTM)
-4,17
Onder sectorgemiddelde (-1,06)
P/B Ratio1,74
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Retail Trade sector mediaan (167 peers)
Sectorvergelijking
vs Retail Trade sector mediaan (167 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -4,2 | -1,1 |
| P/B | 1,7 | 1,1 |
| ROE % | -50,8 | -12,4 |
| Net Margin % | -8,1 | -6,5 |
| Rev Growth 5Y % | -21,5 | 3,2 |
| D/E | 0,1 | 0,5 |
Koersdoel Analisten
5 analisten
Hold
Huidig
€ 4,69
Koersdoel
€ 9,40
€ 7,00
€ 8,00
€ 17,00
Vooruitzicht
Forward WPA
-€ 0,33
Omzet Sch.
1,19 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2027 |
-€ 0,33
-€ 0,54 – -€ 0,15
|
1,19 B | 5 |
| FY2026 |
-€ 0,61
-€ 0,96 – -€ 0,34
|
1,11 B | 6 |
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| 2026 Q2 |
-€ 0,16
-€ 0,22 – -€ 0,07
|
298,12 M | 4 |
| 2026 Q1 |
-€ 0,25
-€ 0,42 – -€ 0,15
|
244,96 M | 4 |
Winstverassingen
Laatste 4 kwartalen
| Kwartaal | Geschat WPA | Werkelijk WPA | Verrassing |
|---|---|---|---|
| Q42025 | -€ 0,22 | -€ 0,16 | +25,6% |
| Q32025 | -€ 0,31 | -€ 0,19 | +38,9% |
| Q22025 | -€ 0,36 | -€ 0,22 | +38,6% |
| Q12025 | -€ 0,63 | -€ 0,42 | +33,2% |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -25,12% | Revenue Growth (3Y) | -18,20% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -21,54% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1,04 B | Net Income (TTM) | -84,62 M |
| ROE | -50,75% | ROA | -21,91% |
| Gross Margin | 24,65% | Operating Margin | -5,86% |
| Net Margin | -8,10% | Free Cash Flow (TTM) | -64,11 M |
| ROIC | -24,44% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,09 | Current Ratio | 1,17 |
| Interest Coverage | -12,12 | Asset Turnover | 2,70 |
| Working Capital | 34,01 M | Tangible Book Value | 151,10 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -4,17 | Forward P/E | N/A |
| P/B Ratio | 1,74 | P/S Ratio | 0,34 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 0,30 | Fwd Earnings Yield | N/A |
| FCF Yield | -18,19% | ||
| Market Cap | 352,49 M | Enterprise Value | 203,11 M |
| Per Share | |||
| EPS (Diluted TTM) | -1,41 | Revenue / Share | 14,15 |
| FCF / Share | -0,87 | OCF / Share | -0,77 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 0,71% | FCF Conversion | 75,76% |
| SBC-Adj. FCF | -78,46 M | Growth Momentum | -3,58 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,04 B | 1,39 B | 1,56 B | 1,93 B | 2,76 B |
| Net Income | -84,62 M | -258,80 M | -307,84 M | -35,24 M | 389,37 M |
| EPS (Diluted) | -1,41 | -5,56 | -6,81 | -0,83 | 8,11 |
| Gross Profit | 257,52 M | 290,16 M | 314,01 M | 443,34 M | 623,90 M |
| Operating Income | -61,21 M | -190,97 M | -118,11 M | 27,01 M | 111,07 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | — | — | — | — |
| SG&A Expenses | — | — | — | — | — |
| D&A | 16,28 M | 19,06 M | 19,45 M | 16,71 M | 18,56 M |
| Interest Expense | 5,05 M | 6,77 M | 1,76 M | 2,97 M | -556.000,0 |
| Income Tax | 825.000,0 | 684.000,0 | 41,72 M | 1,38 M | -48,78 M |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 425,48 M | 401,95 M | 635,82 M | 878,55 M | 1,07 B |
| Total Liabilities | 207,53 M | 239,22 M | 276,69 M | 232,72 M | 321,58 M |
| Shareholders' Equity | 217,58 M | 162,73 M | 359,13 M | 645,83 M | 744,39 M |
| Total Debt | — | — | — | 34,48 M | 37,98 M |
| Cash & Equivalents | 175,30 M | 159,17 M | 302,61 M | 371,26 M | 503,34 M |
| Current Assets | 240,12 M | 227,51 M | 350,07 M | 414,51 M | 551,79 M |
| Current Liabilities | 192,15 M | 224,86 M | 232,40 M | 191,14 M | 272,33 M |
{"event":"ticker_viewed","properties":{"ticker":"BBBY","listing_kind":"stock","pathname":"/stocks/bbby","exchange":"NYSE","country":"US"}}